Markets Business Research Reports Exclusives Economy & Finance Law & Policy

FDA Advisers Vote Against Pfizer-BioNTech Booster Shot

FDA Advisers Vote Against Pfizer-BioNTech Booster Shot

Edward Dufner

(Bloomberg) -- Pfizer shares extend decline on news.

  • Panel’s lack of support is a blow to President Joe Biden’s booster plan
  • Story to follow

©2021 Bloomberg L.P.

Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
GET REGULAR UPDATES

RECOMMENDED FOR YOU

CFO Leaders: The Making Of Five Star CFOs 
timelogo Jan 14, 2021
Stocks Rise, Treasuries Fall on Stimulus Bets: Markets Wrap
timelogo Aug 19, 2019
Stocks End Record-Setting Week With Further Gains: Markets Wrap
timelogo Jul 15, 2019
The Mutual Fund Show: The Dos And Don’ts Of Online Investing
timelogo Apr 27, 2019

POPULAR

1
Musk Makes Surprise China Visit, A Week After Nixing India
2
Boult Eyes Rs 1,000-Crore Revenue In Run-Up To 2025 IPO
3
Cholamandalam General Insurance Records Rs 7,598 Crore Gross Written Premium
4
Nigeria Is Pioneering A New Vaccine To Fight Meningitis. Why This Matters
5
Vedanta Best Placed To Benefit From Rising Commodity Prices, Say Analysts